During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

A U.S. Agency for International Development funding freeze in January forced the closure of India’s Mitr Clinic, the ...

Master injector Alexander Tirado, who brings unmatched passion and intimate knowledge of multiple disciplines, has been ...

At least two dozen bills have been introduced across 15 states this year. Most of the legislation is related to ...

Skin health experts debunk collagen myths, like whether or not collagen supplements really work, and all the ways you can ...

The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones estrogen and progesterone to grow. The goal of so-called endocrine therapy is ...

The legislation will have a major impact on health access and may disrupt who can seek out healthcare essentials, like ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

The case-described by Swedish medics saw a girl grow a 'micropenis' which doctors eventually pinned down to a drug increasingly being marketed to men in the UK and US.

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...

Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...